• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于自动过程控制以最大化运行长度的正态均值(AON)患者数据算法的设计与评估。

Design and assessment of average of normals (AON) patient data algorithms to maximize run lengths for automatic process control.

作者信息

Westgard J O, Smith F A, Mountain P J, Boss S

机构信息

Department of Pathology and Laboratory Medicine, University of Wisconsin Medical School, Madison 53792, USA.

出版信息

Clin Chem. 1996 Oct;42(10):1683-8.

PMID:8855154
Abstract

Achieving high quality and high productivity with automated testing processes will require process control systems that are optimized for the necessary error detection, minimum false rejection, and maximum run length. This study investigates whether run length could be monitored by average of normals (AON) algorithms that truncate the patient test distribution and estimate the average of a suitable number of patient results. The design of AON algorithms for individual analytes is facilitated by computer-simulated power curves that consider the ratio of the population biological variation (Spop) to the test method variation (Smeas), represent a range of Spop/Smeas ratios from 2 to 15, and include numbers of patient test results from 10 to 600. The potential applications of AON algorithms are assessed for 38 tests whose quality requirements represent the total error criteria from the Ontario Medical Association Laboratory Proficiency Testing Program, Spop/Smeas ratios from 0 to 32, critical systematic shifts from 0.02 to 10.85 Smeas, and test workloads representative of a regional reference laboratory. Approximately half of these tests provide high potential for applying AON algorithms to monitor run length.

摘要

要通过自动化测试流程实现高质量和高生产率,将需要针对必要的错误检测、最小误拒收率和最大运行长度进行优化的过程控制系统。本研究调查了运行长度是否可以通过截断患者测试分布并估计适当数量患者结果平均值的正态均值(AON)算法来监测。通过计算机模拟的功效曲线来辅助设计针对单个分析物的AON算法,这些曲线考虑了总体生物学变异(Spop)与测试方法变异(Smeas)的比率,代表了从2到15的一系列Spop/Smeas比率,并包括从10到600的患者测试结果数量。针对38项测试评估了AON算法的潜在应用,这些测试的质量要求代表了安大略省医学协会实验室能力验证计划的总误差标准、从0到32的Spop/Smeas比率、从0.02到10.85 Smeas的关键系统偏移以及代表区域参考实验室的测试工作量。这些测试中约有一半具有应用AON算法监测运行长度的高潜力。

相似文献

1
Design and assessment of average of normals (AON) patient data algorithms to maximize run lengths for automatic process control.用于自动过程控制以最大化运行长度的正态均值(AON)患者数据算法的设计与评估。
Clin Chem. 1996 Oct;42(10):1683-8.
2
Patient population controls.患者群体对照。
Clin Lab Med. 2013 Mar;33(1):139-46. doi: 10.1016/j.cll.2012.11.002. Epub 2012 Dec 20.
3
Analytic clinical laboratory precision--state of the art for thirty-one analysis.分析临床实验室精密度——31项分析的最新技术水平
Am J Clin Pathol. 1980 Oct;74(4 Suppl):521-30.
4
Verification of out-of-control situations detected by "average of normal" approach.通过“正常均值”方法检测到的失控情况的验证。
Clin Biochem. 2016 Nov;49(16-17):1248-1253. doi: 10.1016/j.clinbiochem.2016.07.012. Epub 2016 Jul 21.
5
Exponentially adjusted moving mean procedure for quality control. An optimized patient sample control procedure.用于质量控制的指数调整移动均值程序。一种优化的患者样本控制程序。
Am J Clin Pathol. 1996 Jan;105(1):44-51. doi: 10.1093/ajcp/105.1.44.
6
Selection of medically useful quality-control procedures for individual tests done in a multitest analytical system.为多检测分析系统中进行的单项检测选择具有医学用途的质量控制程序。
Clin Chem. 1990 Feb;36(2):230-3.
7
Use of medians and "average of normals" of patients' data for assessment of long-term analytical stability.使用患者数据的中位数和“正常均值”来评估长期分析稳定性。
Clin Chem. 1996 Jun;42(6 Pt 1):888-92.
8
Serum chloride--a CAP survey.血清氯化物——一项美国病理学家学会调查
Am J Clin Pathol. 1980 Oct;74(4 Suppl):546-51.
9
Choosing quality-control systems to detect maximum clinically allowable analytical errors.选择质量控制系统以检测最大临床允许分析误差。
Clin Chem. 1989 Feb;35(2):284-8.
10
The detection of problem analytes in a single proficiency test challenge in the absence of the Health Care Financing Administration rule violations.在不存在违反医疗保健财务管理局规定的情况下,在单次能力验证挑战中对问题分析物的检测。
Arch Pathol Lab Med. 1993 Apr;117(4):437-43.

引用本文的文献

1
Intelligent Quality Management 2 with IntraSpect™ technology for quality control of GEM® Premier™ 5000 blood gas analyzers- A novel application of the patient sample as its own control.采用IntraSpect™技术的智能质量管理2用于GEM® Premier™ 5000血气分析仪的质量控制——患者样本作为自身对照的新应用。
Pract Lab Med. 2022 Apr 8;30:e00273. doi: 10.1016/j.plabm.2022.e00273. eCollection 2022 May.
2
Comparison and optimization of various moving patient-based real-time quality control procedures for serum sodium.比较和优化各种基于移动患者的血清钠实时质量控制程序。
J Clin Lab Anal. 2021 Oct;35(10):e23985. doi: 10.1002/jcla.23985. Epub 2021 Sep 14.
3
The local clinical validation of a new lithium heparin tube with a barrier: BD Vacutainer® Barricor LH Plasma tube.
一种带隔离装置的新型肝素锂管的局部临床验证:BD Vacutainer® Barricor LH血浆管。
Biochem Med (Zagreb). 2017 Oct 15;27(3):030706. doi: 10.11613/BM.2017.030706. Epub 2017 Aug 28.
4
Collective Opinion Paper on a 2013 AACB Workshop of Experts seeking Harmonisation of Approaches to Setting a Laboratory Quality Control Policy.2013年美国临床生物化学学会专家研讨会关于统一制定实验室质量控制政策方法的集体意见书。
Clin Biochem Rev. 2015 Aug;36(3):87-95.
5
Quality leadership and quality control.质量领导力与质量控制。
Clin Biochem Rev. 2003 Aug;24(3):81-93.